ITPC launches long-acting HIV treatment resources & hosts webinar

Posted on


Long- Acting Injectables for HIV

On 15th February 2024, ITPC Global hosted a Long – Acting HIV Treatment webinar that brought community perspectives into the broader HIV landscape and other global coordination platforms. The webinar explored ARV basics, presented on long-acting HIV treatment and prevention options, and provided insights from communities based on an informative community dialogue that took place in Botswana, South Africa, and Eswatini. 

HIV treatment education remains pivotal to fill knowledge gaps, and most importantly empower communities to advocate for appropriate HIV treatment within the spectrum of new HIV innovations.

Watch the webinar below

Long – Acting HIV Treatment Fact Sheet

This fact sheet provides basic information for and perspectives from communities on long-acting HIV treatment medicines. You can download it here.

Fostering HIV Innovation through Community Engagement

The “Community Voices & Preparedness for New Treatment Innovations” project, spearheaded by the International Treatment Preparedness Coalition (ITPC), is a pivotal initiative seeking to facilitate a constructive dialogue between HIV treatment innovators and communities living with HIV.

The continuous challenge of persistent HIV transmissions and difficulties in achieving viral suppression among certain vulnerable groups underscores the critical need for ongoing innovation in treatment modalities.

At the forefront of these efforts, long-acting injectables (LAIs) are on the path to unlocking improvements in both prevention and treatment. This report provides a high-level summary of three community dialogues conducted at the end of 2023 in Botswana, Eswatini, and South Africa by ITPC in partnership with BONELA, Dream Alive, and NACOSA respectively. The dialogues emphasize the role of community leaders in shaping the narrative around LAIs and the broader HIV treatment landscape.

You can view the resource here.